Fora Health Partnership with The Dartmouth Institute and The Charles Hood Foundation

We are extremely proud to confirm Fora Health is part of a Charles Hood Foundation grant focused on supporting children who receive “off-label” antipsychotic or polypharmacy. For the grant we are working with Professor Glyn Elwyn from The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth. The research team at Dartmouth is led by Erin Barnett, Ph.D., Assistant Professor in Psychiatry and Jennifer McLaren, M.D., Associate Professor in Psychiatry. P, who have developed tools that help clinical prescribers and parents make thoughtful decisions about mental health medications. These tools also, where possible, safely reduce or stop medications (“deprescribe”) in a careful way.

The pilot study will focus on improving the existing intervention, including the use of Fora Health to digitally enable key steps of the intervention, and test how it works with 40 children.

At Fora Health we are very excited to be working with the team at Dartmouth. Of particular relevance for this pilot study are the lessons learnt during the use of Fora Health to support caregivers for and adolescents with Gaucher’s Disease (2022) and also new treatment review functionality in Fora Health, of which an early version has already been deployed for patients being treated for depression at a US statewide community health network (2023).

In addition, we welcome the chance to support shared decision-making and the process of deprescribing for caregivers and patients - as we see these as key foundations for the safe and effective use of all preference sensitive medication use.

If you would like to learn more about our work, or to understand how Fora Health can support Value-Based Care, then please get in touch.

For more information please see the Charles Hood Foundation funding announcement.